mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |